medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2008, Number 3

<< Back Next >>

Rev Mex Patol Clin Med Lab 2008; 55 (3)

Serologic markers of viral hepatitis (A, B, C) in patients with acute and chronic hepatitis

Barriga AG, Arumir EC, Mercado GF, Molina FX

Language: Spanish
References: 35
Page: 143-148
PDF size: 104.92 Kb.


ABSTRACT

We studied and analyzed statistically the results obtained in 3731 serological studies for viral hepatitis A, B, and C, in the same number of patients using and automatized equipment AXYM™ and the MEIA and RIBA techniques. In spite of disponibility of effective vaccine and guidelines for prevention of transmission for the hepatitis B virus, this form was the most frequent type of hepatitis, followed by the type C, combinations of both, and the type A, 25% of the patients with hepatitis B was considered highly infectious by the presence of antigen «e»; the confirmatory test for hepatitis C (RIBA), was positive only in 71.6% of the total repeatedly reactive EIA patients, renal insufficiency and chronic and acute viral hepatitis were the most frequent clinical diagnosis.


REFERENCES

  1. Blumberg BS. Australia antigen, hepatitis and leukemia. Tokio J Med Sci 1968; 76: 1-9.

  2. Blumberg BS. Viral hepatitis and test for the Australia antigen and antibody. Bull Wld Hlth Org 1970; 42: 957-992.

  3. Dane DS, Cameron CH, Briggs M. Virus like particles in serum of patients with Australia antigen associated hepatitis. Lancet 1970; 1: 659.

  4. Choo Q L, Kuo G, Weiner AJ, Overy LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non B. Viral hepatitis genome. Science 1989; 244: 359-362.

  5. Provost PJ, Hilleman MR. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med 1979; 160: 213-221.

  6. Rizzeto M, Canese MG, Arico S. Immunofluorescence detection of a new antigen/antibody system (Delta/anti-Delta) Associated with hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977; 18: 997-1003.

  7. Balayan MSS. Evidence in non – A, non B hepatitis for a virus transmited via the fecal oral route. Intervirology 1983: 20: 23-31.

  8. Zaaijer HL. Hepatitis B virus antibodies among patients with hemophilia, blood donors, and hepatitis patients. J Med Viral 1995; 46: 244-246.

  9. Kruger P, Aldershvile J, Mathiesen LR, Nielsen JO. Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM. Hepatology 1982; 2: 50-53.

  10. Mortimer PP, Vandervelde EM, Lany JV, Cohen BJ, Tedder PS. The Anti – HBc IgM response in the acute and convalescent phases of acute hepatitis. J Infect 1981; 3: 339-347.

  11. Tanaka T, Lau JY, Mikokami M, Orito E, Tanaka E, Kiyosawa K. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis. C viremia. J Hepatol 1995; 23: 742-745.

  12. Pawlotsky JM. Use and interpretation of hepatitis C virus diagnostic assays. Clin Liver Dis 2003; 7: 127-137.

  13. Dimitrakakis M, Walters MJ, Woothen. Detection of IgM antibodies to delta antigen after coinfection and superinfection with delta virus. J Med Virol 1986; 20: 305-311.

  14. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59: 19-24.

  15. Skidmone S. Recombinant immunoblot assay for hepatitis C antibody. Lancet 1990; 335: 1346.

  16. Chardhary R, Maclean C. Evaluation of first and second generation RIBA Kits for detection of antibody to hepatitis C virus. J Clin Microbiol 1991: 29: 2329.

  17. Lisker M. Endemicidad de la hepatitis E. Rev Gast (Mex) 1994 (suppl 2) 59: 143 (Abst 155).

  18. Minihan M. Rising challenge of immunoassay development. Biomedical Scientist 2006; 2: 128-132.

  19. Diepersloot RJA, Zantvliet Y, Oostrom V, Gleaves AC. Comparison of chemoluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen. Clin Diag Lab Immunol 2000; 7(6): 865-866.

  20. Rosner B. Fundamentals of biostatistics. 5th ed. Pacific Grove, Ca: Duxbury Ress, 2000.

  21. Harkness WL, Katz. Comparison of the power functions for the kit of independence in 2 x 2 contingency. Tables. Ann Math Statis 1964; 35: 1115-1127.

  22. Barriga AG, Cano DC, Trejo YS, Villarreal UC, Pérez RG, Ruiz SP. Hepatitis viral aguda: Diagnóstico de laboratorio. Infectología 1985: 4: 106.

  23. Barriga AG, Estrada CM, Trejo YS, Peredo LVMA, Ruiz SP. Avances recientes en seroepidemiología de hepatitis viral B en México. Infectología 1985: 3: 79.

  24. Barriga AG, Yucaipa S, Ruiz SP, Peredo LVMA. Exposición ocupacional a la hepatitis viral del tipo B en un Centro Médico. Rev Med IMSS 1984; 23: 169.

  25. Barriga AG, Banes AG, Portville GA, Trejo YS, Castillo TNP. Seroepidemiología de la hepatitis viral del tipo B en cirujanos dentistas. Rev Med IMSS Mex 1989; 27: 205.

  26. Barriga AG, Trejo YS, Ruiz SP, Peredo LVMA. El medio hospitalario en la transmisión de hepatitis viral B. Infectología 1985; 2: 48.

  27. MMWR Recommendations for Preventing transmission among chronic hemodialysis patients. CDCMMWR 2001 50 (RROS): 1-43.

  28. MMWR Immunization of health-care workers. CDCMMWR 1997, RR18, 46.

  29. Gunson RN, Shouval D, Roggendart M, Zaaijar H, Nicholas H, Holzmann H. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in health care worker. (HCWs) guidelines for prevention of transmission o/HBV and HVC from HCW to patients. J Clin Virol 2003; 27: 213-230.

  30. Favero MS, Maynard JE. Peterson NJ. Hepatitis B antigen on environmental surfaces. Lancet 1973; 2: 1455.

  31. Soriano V, Pouti M, Bonacini M. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from a HIV-HBV international. Panel AIDS 2005; 18, 19(3): 221-240 .

  32. Bond WW, Favero MS, Peterson NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1: 550-551.

  33. Mortimer D. Review article: Hepatitis B and liver transplantation. Aliment Pharmacol Ther 2006; 23: 1031-1041.

  34. McMahon BJ. Epidemiology and natural history of hepatitis B. Sem Liver Dis 2005; 25 (suppl 1): 3-8.

  35. Omana VN, Gouliang X, Vaughan G, Margolis HS. Diagnosis of hepatitis A infection: A Molecular approach. Clin Microb Rev 2006; 19, 1: 63-79.




2020     |     www.medigraphic.com